Immunocore appoints Baker Bros partner Krishana to board; grants registration rights to BBA funds

Immunocore Holdings plc

Appointed Ranjeev Krishana (Baker Bros partner) as Class I director, effective May 28, 2024.
Standard director compensation includes option grant valued at ~$325,790.
Entered Registration Rights Agreement with BBA funds for resale of shares held by them.
BBA can request resale registration within 60 days; up to one underwritten offering per year.
Amendment lowered director nomination threshold from 75% of shares to fixed 1,029,652 ADSs.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ranjeev Krishana

Class I director

IMCR · Immunocore Holdings plc

Effective: 2024-05-28
Filed: May 28, 2024, 7:59 PM ET

the Board appointed Mr. Ranjeev Krishana to serve as a Class I director of the Company, effective May 28, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Ranjeev Krishana was appointed as Class I director at Immunocore Holdings plc.

Action: appointed
Role: Class I director

Exact text from the filing

the Board appointed Mr. Ranjeev Krishana to serve as a Class I director of the Company, effective May 28, 2024.

View on SEC.gov

Immunocore Holdings plc filing history →

Source: SEC EDGAR

accession 0001140361-24-027667

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.